Created On: 2020-07-15
Record Count: 4
IPSCIO Report Record List
Below you will find the records curated into this collection. This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs. The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms. For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report
IPSCIO Record ID: 7481
Biological Property shall mean any DNA materials, derivatives of such DNA materials, cell lines and peptides containing the DNA materials or derivatives thereof, that are related to the TGF-B Antibody Patent Rights, and to the TGF-B Receptor Patent Rights, respectively.
TGF-B Antibody Patent Rights shall mean the Patent Rights that relate to monoclonal antibodies that bind Transforming Growth Factor ('TGF-B'), specifically TGF-B1 and TGF-B2.
TGF-B Receptor Patent Rights Licensed from MIT shall mean the Patent Rights that relate to TGF-B receptors, including TGF-B type II and TGF-B type III receptors, cDNA of the respective receptors, and methods of use.
IPSCIO Record ID: 4451
'Initial Indications' means the indications for wound repair and multiple sclerosis; 'Initial Products' shall mean Products for the Initial indications.
'TGF-B' means any and all transforming growth factor Betas (1,2,3,etc) and any fragments, analogs, derivatives or modifications thereof which provides essentially the same biological function as transforming growth factor Betas, including all uses of the foregoing owned, licensed and/or developed by Licensor
'TGF-B2' means transforming growth factor Beta 2 as described in U.S. Patent # 4,774,322.
IPSCIO Record ID: 29291
IPSCIO Record ID: 26674